News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Nuvation Bio added over 200 IBTROZI patients per quarter and accelerating revenue, underpinning a tactical long trade.
  • Eaton beat quarterly expectations and raised guidance on AI data center demand and grid modernization, making the post-pullback stock a long idea.
  • Oracle completed a $10B equity raise at $116, creating a near-term floor and a focused tactical long opportunity.
  • AI infrastructure demand is supporting industrials and enterprise tech, suggesting re-rate potential for exposed stocks.
  • Biotech conversion gaps and legal noise are keeping certain names depressed, raising idiosyncratic risk for sector investors.

Latest Articles

Vistagen to Present at Psych Congress 2026

Vistagen to Present at Psych Congress 2026

Vistagen, a Nasdaq-listed biopharmaceutical company, announced it will present encouraging efficacy data from its Phase 3 trials of fasedienol nasal spray for very severe social anxiety disorder at Psych Congress 2026. The intranasal product aims to offer rapid therapeutic benefits via a novel pherine mechanism targeting nose-to-brain neurocircuitr…

Stifel Deepens Fixed Income Platform with Senior Talent

Stifel Deepens Fixed Income Platform with Senior Talent

Stifel Financial Corp. appointed Conor Daly and Jim Franz as Co-Heads of Leveraged Finance Sales in Europe, enhancing its global Fixed Income platform. The hires bring extensive experience and established investor relationships, aligning with Stifel's strategy to expand its Fixed Income business in Europe and provide comprehensive financing solutio…

BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference

BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference

BioCardia, Inc. announced that CEO Dr. Peter Altman will present at the H.C. Wainwright 28th Annual Global Investment Conference, highlighting advancements in CardiAMP autologous cell therapy regulatory submissions in Japan and the US, the ongoing CardiAMP HF II pivotal trial, and developments in their Helix delivery and Heart3D imaging platforms. …

NextNRG Announces 1-for-10 Reverse Stock Split

NextNRG Announces 1-for-10 Reverse Stock Split

NextNRG, Inc., an AI-driven energy innovation company listed on Nasdaq under the ticker NXXT, announced a 1-for-10 reverse stock split effective September 14, 2026. This action will reduce the outstanding shares from approximately 168.4 million to 16.8 million, aiming to consolidate the share structure without impacting overall company value. The c…

Snail Games to Present at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14, 2026, at 4:00 p.m. ET

Snail Games to Present at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14, 2026, at 4:00 p.m. ET

Snail, Inc., a Nasdaq-listed global developer and publisher of interactive digital entertainment, announced its scheduled presentation and one-on-one meetings at the H.C. Wainwright 28th Annual Global Investment Conference held September 14-16, 2026 in New York City. Management will present on September 14 at 4:00 p.m. ET, with the presentation ava…

Leonardo DRS Awarded $96 Million in Contracts to Provide Critical MK 41 Vertical Launching System Electronics Hardware

Leonardo DRS Awarded $96 Million in Contracts to Provide Critical MK 41 Vertical Launching System Electronics Hardware

Leonardo DRS has been awarded contracts totaling $96 million to provide advanced electronics hardware for the U.S. Navy's MK 41 Vertical Launching System, a widely deployed naval missile launching system used by the U.S. and allied navies. The company will supply Programmable Power Supplies, Launch Control Units, and Transformer Platforms essential…

Mint’s Majority Owned Subsidiary Rice Robotics Hong Kong Enters into Non-Exclusive Framework Cooperation Agreement with Vengine to Scale Manufacturing Network

Mint’s Majority Owned Subsidiary Rice Robotics Hong Kong Enters into Non-Exclusive Framework Cooperation Agreement with Vengine to Scale Manufacturing Network

Mint Incorporation Limited (NASDAQ: MIMI) announced that its majority-owned subsidiary Rice Robotics Hong Kong entered into a non-exclusive Framework Cooperation Agreement with Vengine. The agreement aims to explore collaboration in product development, manufacturing support, and distribution to scale mass production and expand market reach in Asia…

ZenaTech Secures Irish Aviation Authority Operational Authorization for Drone-Based Crop and Soil Nutrient Application Services

ZenaTech Secures Irish Aviation Authority Operational Authorization for Drone-Based Crop and Soil Nutrient Application Services

ZenaTech, Inc., a Nasdaq-listed AI drone and Drone as a Service (DaaS) company, announced that its subsidiary ZenaDrone received Specific Operations Risk Assessment (SORA) approval from the Irish Aviation Authority. This authorization permits large-scale drone-based application of fertilizers and soil nutrients on Irish farmland, marking a signific…

Private Markets and AI Emerge as Defining Priorities for Asset Managers as Regional Priorities Shape Growth Strategies

Private Markets and AI Emerge as Defining Priorities for Asset Managers as Regional Priorities Shape Growth Strategies

Nasdaq's 2026 Global Voice of the Issuer Study reveals private markets lead client demand globally across all regions, with 80% of asset managers using AI in product development though only 26% use it broadly across stages. Despite identifying growth areas, firms face difficulties scaling new products due to a crowded market and distribution challe…

Vista Gold Has a Path to Value; Wait for a Cleaner Entry

Vista Gold Has a Path to Value; Wait for a Cleaner Entry

Vista Gold (VGZ) is a development-stage gold company with a completed Mt Todd feasibility study and a clean balance sheet. Market cap (~$323M) and cash ($33.9M) give the company runway, but negative cash flow, execution and financing risk argue for waiting for a lower entry. Our trade plan: enter at $1.80, stop $1.40, target $3.00 over ~180 trading…

Tokyo Electron: Fat-Tail Upside From the Next Fab Cycle

Tokyo Electron: Fat-Tail Upside From the Next Fab Cycle

Tokyo Electron (TOELY) is a high-quality semiconductor-equipment franchise that should materially benefit from a renewed industry capex cycle. The company's durable moat, strong margin profile, and leadership in critical process tools create asymmetric upside versus the downside of a cyclical pause. This trade idea lays out an actionable long with …

Inuvo to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th

Inuvo to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th

Inuvo, Inc., a provider of AI advertising technology solutions, announced it will present and participate in one-on-one meetings at the H.C. Wainwright 28th Annual Global Investment Conference on September 14-16, 2026, in New York City. The presentation will highlight their patented IntentKey AI technology that models media audiences for improved p…

Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer

Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer

Oncolytics Biotech reported positive preclinical results demonstrating that their immunotherapy pelareorep maintains activity when combined with a pan-RAS inhibitor in RAS-driven colorectal cancer models. The combination reduced tumor growth effectively, supporting further studies to optimize dosing and evaluate pelareorep's potential to deepen and…

MAIA Biotechnology Delivers Oral and Poster Presentations Showcasing Next-Generation Telomere-Targeting Cancer Therapies at IRT 2026

MAIA Biotechnology Delivers Oral and Poster Presentations Showcasing Next-Generation Telomere-Targeting Cancer Therapies at IRT 2026

MAIA Biotechnology showcased its second-generation telomere-targeting drug candidates at the XXVI International Round Table on Nucleosides, Nucleotides and Nucleic Acids (IRT 2026). The presentations emphasized the potential of MAIA's novel divalent prodrug molecules, which combine the lead agent ateganosine with complementary DNA-targeting agents …